Holen Sie sich die Stockscreener-App
32.13
3.88%
1.20
Schlusskurs vom Vortag:
$30.93
Offen:
$31.26
24-Stunden-Volumen:
1.23M
Relative Volume:
1.48
Marktkapitalisierung:
$2.55B
Einnahmen:
$517.15M
Nettoeinkommen (Verlust:
$66.35M
KGV:
39.13
EPS:
0.8212
Netto-Cashflow:
$126.63M
1W Leistung:
-5.08%
1M Leistung:
-10.18%
6M Leistung:
+4.05%
1J Leistung:
+5.59%
1-Tages-Spanne:
$31.06
$32.31
1-Wochen-Bereich:
$30.62
$34.16
52-Wochen-Spanne:
$22.61
$50.71
Veracyte Inc Stock (VCYT) Company Profile
Firmenname
Veracyte Inc
Sektor
Branche
Telefon
(650) 243-6300
Adresse
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
32.13 | 2.55B | 517.15M | 66.35M | 126.63M | 0.8212 |
|
TMO
Thermo Fisher Scientific Inc
|
464.37 | 172.51B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
187.32 | 132.46B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
573.82 | 45.69B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.51 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
286.57 | 28.11B | 3.17B | 642.63M | 516.49M | 10.77 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Underweight |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Hold |
| 2025-03-20 | Eingeleitet | Craig Hallum | Buy |
| 2024-12-05 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-10-16 | Eingeleitet | UBS | Buy |
| 2024-10-10 | Eingeleitet | Guggenheim | Buy |
| 2024-02-23 | Bestätigt | Needham | Buy |
| 2023-01-18 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-01-07 | Eingeleitet | Stephens | Overweight |
| 2021-11-18 | Fortgesetzt | Goldman | Buy |
| 2021-06-15 | Eingeleitet | Raymond James | Outperform |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Underweight |
| 2019-07-31 | Eingeleitet | Lake Street | Buy |
| 2019-07-02 | Eingeleitet | Needham | Buy |
| 2018-11-29 | Herabstufung | Janney | Buy → Neutral |
| 2018-10-31 | Hochstufung | Janney | Neutral → Buy |
| 2017-11-07 | Herabstufung | Janney | Buy → Neutral |
| 2017-11-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | Fortgesetzt | BTIG Research | Buy |
| 2016-11-14 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-18 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-06-11 | Bestätigt | Leerink Partners | Outperform |
| 2013-11-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Veracyte Inc Aktie (VCYT) Neueste Nachrichten
Veracyte, Inc. $VCYT Stock Holdings Lifted by First Trust Advisors LP - MarketBeat
Veracyte (VCYT) CAO awarded 10,525 RSUs in new equity grant - Stock Titan
Veracyte (VCYT) grants CEO Marc Stapley 92,099 RSUs vesting from 2027 - Stock Titan
Veracyte CFO Chambers sells $662k in VCYT stock - Investing.com Nigeria
Panic Selling: Can Veracyte Inc. ride the EV waveWeekly Trade Analysis & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Veracyte at Leerink Global Healthcare: Strategic Growth Focus By Investing.com - Investing.com Canada
Are Veracyte's (VCYT) Strong 2025 Profits and Reaffirmed 2026 Outlook Redefining Its Growth Story? - simplywall.st
Veracyte CFO Chambers sells $662k in VCYT stock By Investing.com - Investing.com Canada
Insider Sell: Rebecca Chambers Sells Shares of Veracyte Inc (VCY - GuruFocus
Veracyte (NASDAQ:VCYT) CFO Rebecca Chambers Sells 18,341 Shares - MarketBeat
VCYT: Morgan Stanley Lowers Price Target Amidst Underweight Rati - GuruFocus
Morgan Stanley Lowers Price Target on Veracyte to $37 From $48, Keeps Underweight Rating - marketscreener.com
Morgan Stanley cuts Veracyte stock price target on valuation methodology By Investing.com - Investing.com Canada
Morgan Stanley cuts Veracyte stock price target on valuation methodology - Investing.com
Veracyte, Inc. $VCYT Shares Sold by GW&K Investment Management LLC - MarketBeat
Veracyte, Inc. $VCYT Shares Acquired by ARK Investment Management LLC - MarketBeat
Affiliate to sell 6,658 Restricted Stock Units — VCYT (NASDAQ: VCYT) - Stock Titan
[144] VERACYTE, INC. SEC Filing - Stock Titan
Marc Stapley (NASDAQ: VCYT) reports sale of 15,000 shares for $1.92M - Stock Titan
Veracyte Insider Sold Shares Worth $485,429, According to a Recent SEC Filing - marketscreener.com
Veracyte (NASDAQ: VCYT) VP has 3,006 shares withheld for taxes - Stock Titan
Veracyte (VCYT) CFO reports 7,234-share tax withholding, not a sale - Stock Titan
[Form 4] VERACYTE, INC. Insider Trading Activity - Stock Titan
Veracyte (VCYT) exec sells 13,425 shares, 117,346 remain - Stock Titan
Veracyte (VCYT) CEO has 19,455 shares withheld to cover taxes - Stock Titan
Segall Bryant & Hamill LLC Has $18.31 Million Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
Champlain Investment Partners LLC Makes New $40.06 Million Investment in Veracyte, Inc. $VCYT - MarketBeat
VCYT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Veracyte, Inc. (VCYT) Stock Analysis: Uncovering A Promising 34.96% Upside For Investors - DirectorsTalk Interviews
William Blair Investment Management LLC Buys New Stake in Veracyte, Inc. $VCYT - MarketBeat
Veracyte (VCYT) Valuation Check After Strong 2025 Earnings And Reaffirmed 2026 Growth Outlook - Yahoo Finance
JPMorgan Chase & Co. Has $17.81 Million Position in Veracyte, Inc. $VCYT - MarketBeat
Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
Cathie Wood’s ARK sells Veracyte stock, buys MercadoLibre - Investing.com South Africa
Cathie Wood’s ARK sells Veracyte stock, buys MercadoLibre By Investing.com - Investing.com Nigeria
Veracyte Inc. Signals Durable Growth in Earnings Call - TipRanks
Veracyte, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:VCYT) 2026-03-02 - Seeking Alpha
Veracyte (VCYT) CCO John Leite receives PSU shares, withholds stock for taxes - Stock Titan
Veracyte (VCYT) CEO reports PSU vesting and tax withholding share disposition - Stock Titan
Veracyte (VCYT) CFO granted shares as PSUs vest, with tax shares withheld - Stock Titan
Veracyte (NASDAQ: VCYT) officer gets PSU vesting, withholds shares - Stock Titan
Veracyte (VCYT) SVP awarded 50,999 shares; some withheld for taxes - Stock Titan
How Veracyte’s Profit Jump and 2026 Outlook Will Impact Veracyte (VCYT) Investors - simplywall.st
Vanguard Group Inc. Raises Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Veracyte Stock Soars 8.48%, Hits Intraday High of $39.89 - Markets Mojo
Veracyte (VCYT) Margin Expansion To 12.8% Tests Bullish Profitability Narratives - simplywall.st
Veracyte, Inc. (NASDAQ:VCYT) Q4 2025 Earnings Call Transcript - Insider Monkey
Decoding Veracyte Inc (VCYT): A Strategic SWOT Insight - GuruFocus
Artisan Partners Limited Partnership Acquires 1,048,692 Shares of Veracyte, Inc. $VCYT - MarketBeat
VCYT Gains Analyst Support: Needham Raises Price Target | VCYT S - GuruFocus
Finanzdaten der Veracyte Inc-Aktie (VCYT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Veracyte Inc-Aktie (VCYT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Stapley Marc | Chief Executive Officer |
Mar 04 '26 |
Sale |
35.97 |
45,523 |
1,637,594 |
357,554 |
| Leite John | Chief Commercial Officer-CLIA |
Mar 04 '26 |
Sale |
35.19 |
5,260 |
185,083 |
107,580 |
| McGuire Annie | SVP, General Counsel |
Mar 04 '26 |
Sale |
35.55 |
6,658 |
236,725 |
94,706 |
0.34%
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):